Teva Pharmaceutical Industries purchases Allergan's generics business for $40.5-billion. This may help generic-drug makers to acquire products that may be divested s part of the antitrust procedures in the US and fill their portfolio gaps. Teva ... MedIndia, 1 month ago
Teva-Allergan deal a booster for Indian companies - Economic Times, 1 month ago
/PRNewswire/ -- Biosimilar Drugs - Discover Revenue Potential Now, Benefiting Your Authority Do you want to fully understand the sales potentials for biosimilars ? This new analysis provides you with revenue forecasts to 2025 at overall world ...Sys-Con Media, 1 month ago
on your WebpageAdd Widget >Get your members hooked!